Advertisement

Topics

Latest "Cambridge Healthtech Institute" News Stories

13:34 EDT 26th April 2018 | BioPortfolio

Here are the most relevant search results for "Cambridge Healthtech Institute" found in our extensive news archives from over 250 global news sources.

More Information about Cambridge Healthtech Institute on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Cambridge Healthtech Institute for you to read. Along with our medical data and news we also list Cambridge Healthtech Institute Clinical Trials, which are updated daily. BioPortfolio also has a large database of Cambridge Healthtech Institute Companies for you to search.

Showing "Cambridge Healthtech Institute" News Articles 1–25 of 5,200+

Thursday 26th April 2018

South Florida Institute on Aging to Host Annual Caregiver Symposium: Technology and Caregiving at a Crossroads

Scheduled for June 22, the symposium to focus on South Florida’s caregiving needs The second annual Caregiver Symposium hosted by The South Florida Institute on Aging (SoFIA) and the Caregiver Coalition of South Florida will be offered on Friday, June 22 from 8:30 a.m. to 4 p.m. at the H. Wayne Huizenga College of Business and Entrepreneurship DeSant...


Pharnext Appoints Amit Kohli as Chief Operating Officer

Regulatory News: Pharnext SA (Paris:ALPHA) (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drug combinations based on big genomic data and artificial intelligence, today announced the appointment of Amit Kohli, a senior healthcare industry executive, as C

OncLive® To Induct the 2018 Class of Giants of Cancer Care®

OncLive® is proud to announce the inductees of the 2018 Giants of Cancer Care® recognition program. This year, 21 respected healthcare professionals who are advancing the field of oncology by their contributions in research and clinical practice will be awarded. The winners will be celebrated on May 31 during an exclusive celebration, from 7:00 pm - 10:0...


Alabama Organizations Awarded $10M NIH Grant for Newborn Genome Sequencing Project

Heather LandiThe National Institutes of Health (NIH) has awarded a four-year, $10 million grant to HudsonAlpha Institute for Biotechnology, a Huntsville, Ala.-based genomics and genetics research institute, in collaboration with the University of Alabama at Birmingham (UAB) School of Medicine and the University of Mississippi Medical Center, to investigate how genome sequencing can help with the d...

17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies: Koch Institute, MIT Kresge Auditorium, June 15, 2018, 9AM-4PM

17th annual Summer Symposium: Breakthrough Cancer Nanotechnologies: Koch Institute, MIT Kresge Auditorium, June 15, 2018, 9AM-4PM   FEATURED SPEAKERS AND PANELISTS   Noubar Afeyan, PhD Founder and CEO, Flagship Pioneering   Daniel Anderson, PhD Samuel A. Goldblith Professor of Applied Biology, MIT Associate Professor, Chemical Engineering and Institute for Medical Engineering and Science, ...

Anti-Mesothelin Monoclonal Antibodies for the Treatment of Cancer

The National Cancer Institute, Laboratory of Molecular Biology seeks parties interested in collaborative research to further co-develop monoclonal antibodies for the treatment of mesothelin-expressing cancers. The antibody was able to inhibit tumor growth in mouse xenograft models, and corresponding immunotoxins were able to inhibit tumor cell growth in vitro Mesothelin is a cell surface protein t...

Glial Cell Line-Derived Neurotrophic Factor for the Treatment of Neurodegenerative Diseases and Diabetes

The National Institute on Drug Abuse (NIDA) is seeking interested parties to license or co-develop GDNFOS peptides and non-coding RNAs as therapeutic agents for neurodegenerative diseases. Glial cell line-derived neurotrophic factor (GDNF) is a small human protein encoded by the GDNF gene. GDNF has been effective therapy in laboratory animal models of Parkinson's disease and protects several types...

Nitric Oxide Based Therapeutics for the Treatment of Lung Cancer

Nitric oxide (NO) has a broad spectrum of actions in physiological and pathological processes.  NO-donor drugs have shown therapeutic effect in several cancer types by inducing apoptosis but the concentrations required have suggested limited clinical applicability.  For cancers such as non-small cell lung cancer where most therapies are not curative, there remains a need for effective treatments...

High-Affinity Mouse Monoclonal Antibodies to GPC-3 for Liver Cancer Research

The National Cancer Institute Laboratory of Molecular Biology seeks parties for collaborative research to co-develop and commercialize antibody drug/toxin conjugates as liver cancer therapy and diagnostics.  There is great interest and value in developing more sensitive and efficient agents for earlier detection of hepatocellular cancer (HCC).  Glypican-3 (GPC3) is a cell surface heparin sulfate...

Engineered Biological Pacemakers

The National Institute on Aging's Cellular Biophysics Section is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize biological pacemakers. A common symptom of many heart diseases is an abnormal heart rhythm or arrhythmia.  While effectively improving the lives of many patients, implantable pacemakers have s...

Sterculic Acid Treatment for Choroidal Neovascularization

Sterculic acid is a naturally occurring cyclopropene acid present in kapok seed oil, cottonseed oil, and in the seeds of the Sterculia foetida tree.  Sterculic acid has been reported to be a non-specific inhibitor of stearoyl-Co desaturase (SCD), which has been implicated in several disease states, including cardiovascular disease, obesity, non-insulin-dependent diabetes mellitus, skin disease, h...

New Cancer Research Model: Spontaneously Transformed Mouse Epithelial Cancer Cell Lines

The National Cancer Institute Cancer Genetics Branch is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize mouse epithelial cancer cell lines. Investigators at the NIH have created a collection of 45 mouse epithelial cancer cell lines derived from six organs: bladder, cervix, colon, lung, kidney, and mammar...

Agonistic Human Monoclonal Antibodies against Death Receptor 4 (DR4)

The National Cancer Institute is seeking parties interested in licensing human monoclonal antibodies (mAbs) that bind to death receptor 4 ("DR4"). The tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and its functional receptors, DR4 and DR5, have been recognized as promising targets for cancer treatment.  Therapeutics targeting TRAIL and its receptors are not only effective ...

Mouse Xenograft Model for Mesothelioma

The National Cancer Institute is seeking parties interested in collaborative research to co-develop, evaluate, or commercialize a new mouse model for monoclonal antibodies and immunoconjugates that target malignant mesotheliomas.  Applications of the technology include models for screening compounds as potential therapeutics for mesothelioma and for studying the pathology of mesothelioma. This i...

Nitroxyl (HNO) Releasing Therapeutics

Nitroxyl (HNO) has recently emerged as a prospective pharmacological agent.  Studies of the chemistry of HNO have led to an understanding that HNO is vastly different from nitric oxide (NO). HNO displays unique cardiovascular properties and has been shown to have positive effects in failing hearts without changing heart rate, and also has been shown to have beneficial effects in ischemia reperfus...

GATA-3 Reporter Plasmids for Revealing Underlying Mechanisms in Breast Cancer

GATA-3 is a transcription factor that is highly expressed in normal cells of the mammary luminal epithelium. GATA-3 plays a regulatory role in determining the fate of cells in the mammary gland. Disruption of GATA-3 expression leads to defects in the development of mammary cells, including an inability to differentiate properly into the correct cell type. GATA-3 function is also disrupted in vario...

Software for Modeling Delivery and Penetration of Antibody Conjugates

The National Cancer Institute (NCI)  Laboratory of Molecular Biology is seeking parties to license software for modeling the targeted delivery of anti-cancer agents in solid tumors. The software models the permeability and concentration of intravenously administered antibody anti-cancer agent conjugates in solid tumors.  The models can be used to determine optimal dosing regimen of a therapeuti...

Selective Treatment of Cancer Cells, HIV and Other RNA Viruses

The National Cancer Institute seeks parties interested in collaborative research to co-develop therapeutic RNA switches. Targeted therapy in cancer or viral infections is a challenge because the disease state manifests itself mainly through differences in the cell interior, for example in a form of the presence of a certain RNA or protein in the cytoplasm. This technology, developed at the NCI Nan...

Enhanced Cancer Immunotherapy Using microRNA-155

The National Cancer Institute’s Surgery Branch seeks parties to co-develop the use of  miR155 CD8+ T cells as an adoptive immunotherapy to treat cancer. Scientists at the NIH recently discovered that the overexpression of microRNA-155 (miR-155) in tumor-reactive murine CD8+ T cells can enhance T cell proliferation and anti-tumor efficacy without lymphodepletion and exogenous cytokine administra...

Improved Antibodies Against ERBB4/HER4

The Eunice Kennedy Shriver National Institute of Child Health and Human Development, Section on Molecular Neurobiology is seeking statements of capability or interest from parties interested in collaborative research to further evaluate or commercialize specific rabbit monoclonal antibodies generated against the ErbB4 receptor (also known as HER4) that have been validated for specificity using tis...

Diagnostic Marker for Improving Treatment Outcomes of Hepatitis C

The National Cancer Institute (NCI) Division of Cancer Epidemiology and Genetics (DCEG)  Immunoepidemiology Branch is seeking statements of capability or interest from parties interested in collaborative research to further co-develop a gene-based diagnostic for Hepatitis C virus (HepC, HCV). NCI Researchers have discovered Interferon-lambda 4 (IFNL4), a protein found through analysis of genomic ...

Software for Accurate Segmentation of Cell Nuclei in Breast Tissue

The Office of the Director, National Cancer Institute is seeking statements of capability or interest from parties interested in collaborative research (using the Cooperative Research and Development Agreement (CRADA) or Material Transfer Agreement (MTA) to further develop, evaluate, or commercialize the software for accurate segmentation of cell nuclei and FISH signals in tissue sections.  Colla...

Lentiviral Vectors with Dual Fluorescence/Luminescence Reporters

The National Cancer Institute’s Protein Expression Laboratory seeks parties to co-develop dual luminescent/fluorescent cancer biomarkers. In research settings, visualization of  tumors or tumor cells is often done using either bioluminescence or fluorescence.  However, both of these methods have shortcomings: bioluminescence is not sensitive enough to sort individual tumor cells, and fluoresce...

Micro Medical Solutions Announces International Scientific Advisory Board to Guide and Advance Clinical Development

To accelerate study of the MicroStent microvascular device and other new technologies designed to prevent amputation, MMS has assembled six world leaders in treating peripheral artery disease and critical limb ischemia. Micro Medical Solutions (MMS), an innovator in the field of microvascular interventions that improve clinical outcomes and quality of ...

CSIP Encourages Consumers to Participate in National Prescription Take Back Day on April 28; Google Announces New Online Tools to Help Consumers

Participating in DEA’s annual event helps families properly dispose of unused or expired medicines and prevent addiction where it most often starts – at home. WASHINGTON (PRWEB) April 26, 2018 The Center for Safe Internet Pharmacies (CSIP) and its members are encouraging Americans to do their part to help curb opioid abuse and accidental drug poisoning by participating in the U.S. Drug Enforc...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks